Recently, AlphaMol received milestone payments from both Shanghai Pharma and Salubris Pharma for the co-developing orphan GPCR drug discovery pipeline. AlphaMol continue to work closely with partners for the joint new drug discovery projects.
Recently, AlphaMol received milestone payments from both Shanghai Pharma and Salubris Pharma for the co-developing orphan GPCR drug discovery pipeline. AlphaMol continue to work closely with partners for the joint new drug discovery projects.